Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge
Author(s) -
Emilie R Elliot,
Alieu Amara,
Nicole Pagani,
Laura Else,
Graeme Moyle,
Alex Schoolmeesters,
Chris Higgs,
Saye Khoo,
Marta Boffito
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx145
Subject(s) - cobicistat , atazanavir , darunavir , pharmacokinetics , pharmacology , medicine , urine , ritonavir , saliva , virology , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom